@misc{Słota_Ewa_BSE_2002,
 author={Słota, Ewa and Natonek, Małgorzata and Żyga, Agata and Rejduch, Barbara},
 volume={56},
 number={1},
 copyright={Creative Commons Attribution BY-SA 4.0 license},
 journal={Biotechnologia, vol.56, 1 (2002)-.},
 howpublished={online},
 year={2002},
 publisher={Committee on Biotechnology PAS},
 publisher={Institute of Bioorganic Chemistry PAS},
 language={pol},
 abstract={Prion diseases (for example: scrape of sheep, BSE, CJD of humans) areamong the most notable central nervous system degenerative disorders causedby the accumulation of modified cellular protein. The conversion of PrP(C) (thenormal cellular protein) into PrP(Sc) (the abnormal disease-causing isoform) involves a conformation change whereby the a-helical content diminishes and theamount of P sheet increases. PrP (Sc) is partially resistant to proteases, temperature, high and low pH. Because the incidence of prion diseases is due to severalfactors, various efforts need to be taken to reduce the scale and consequencesof the disease. They include post-mortem and in vivo diagnosis and prophylactics, i.e. monitoring of animals and feed control.},
 title={BSE - Identification and prophylactics},
 type={Text},
 URL={http://www.rcin.org.pl/Content/138406/PDF/POZN271_173768_biotechnologia-2002-no2-slota.pdf},
 keywords={biotechnology},
}